Advanced Cases in Pediatric Fever Without a Source - PowerPoint PPT Presentation

1 / 40
About This Presentation
Title:

Advanced Cases in Pediatric Fever Without a Source

Description:

What are the risk factors for SBI and UTI in febrile infants? ... Ampicillin and gentamicin IV, or ampicillin and cefotaxime IM. Admission ... – PowerPoint PPT presentation

Number of Views:90
Avg rating:3.0/5.0
Slides: 41
Provided by: sfghde
Category:

less

Transcript and Presenter's Notes

Title: Advanced Cases in Pediatric Fever Without a Source


1
Advanced Cases in Pediatric Fever Without a Source
  • Andi Marmor
  • June, 2004

2
Key Questions
  • What are the risk factors for SBI and UTI in
    febrile infants?
  • How effective is the pneumococcal vaccine?
  • Partial vaccination
  • Technical difficulties when the best laid plans
    go awry
  • How do you collect urine?
  • Do viruses count as a fever source?

3
Fever Without a Source A Quick Review
  • For nearly 20 of febrile children, no source of
    infection can be identified after thorough
    history and physical exam
  • A small proportion of these children, although
    well-appearing, will have a serious bacterial
    infection (SBI) or occult urinary tract infection
    (UTI)
  • Guidelines have been developed to help physicians
    identify and treat those children at high risk
    for these conditions

4
Age Groups for Estimating Risk of SBI in
Well-Appearing Infants
  • Guidelines for management of infants with fever
    without a source are based on groupings of
    infants into 3 age groups based on both their
    risk of SBI/UTI and the most likely bacterial
    causes of SBI
  • Neonate (0-28 days)
  • Infant 1-3 mo
  • Infant 3-36 mo

5
Neonates (lt28 days)
  • Causes of SBI/UTI
  • E. Coli, GBS, Listeria, Salmonella
  • What counts as a fever source?
  • Clinical exam is unreliable, and even infants
    with viral symptoms may be at risk for SBI
  • Prevalence of SBI in well-appearing infants lt28
    days with Tgt38
  • 4-12
  • UTI
  • Prevalance of UTI is high for boys and girls
  • Associated with a 15-20 risk of bacteremia

6
RecommendationsNeonates, T gt38
  • CBC, blood cultures
  • Cath UA and urine culture
  • LP
  • Antibiotics
  • Ampicillin and gentamicin IV, or ampicillin and
    cefotaxime IM
  • Admission

7
Infants 1-3 months of age
  • Causes of SBI/UTI
  • E. Coli (UTI), GBS, S. pneumonia, N.
    meningitidis, Hib
  • What counts as a fever source?
  • Named viral syndrome
  • Otitis media
  • Other viruses?
  • Prevalence of UTI in this age group is about 9
    overall, (highest in uncirc boys, but only 2 in
    circumcised boys)

8
Infants 1-3 months of age Predictors of SBI
  • Studies in the early 90s established criteria
    for dividing well-appearing febrile infants this
    age into groups at high or low risk for SBI based
    on WBC count
  • WBC 5-15 Risk of SBI (NOT including UTI) is
    1-3
  • High risk 10-20

9
Recommendations 1-3 months, Tgt38
  • Cath urinalysis and urine culture on all infants
  • If UA is positive, begin treatment for
    pyelonephritis and consider admission
  • CBC and blood culture
  • If WBCgt15K, antibiotics (ceftriaxone IM/IV)
  • Lumbar puncture
  • If signs of CNS irritability, and strongly
    consider if giving antibiotics
  • Follow up
  • The next day (2nd dose if antibiotics were given)
  • Admit if unable to follow up

10
Infants 3-36 months, Tgt38.5
  • Causes of SBI
  • S. pneumoniagtgtgtN. meningitidis, Hib
  • Causes of UTI
  • E. ColigtgtgtKlebsiella, Proteus, Strep spp
  • Risk highest in girls and in uncirc boys up to
    6-12 mo
  • Risk for SBIbefore pneumococcal vax
  • Overall risk of SBI in these infants estimated
    2-6
  • WBC count useful to stratify infants into high
    risk (10) and low risk (1)

11
Hooray for the pneumococcal vaccine!
  • 7-valent polysaccharide conjugate vaccine
  • Approximately 97 of pneumococcal isolates that
    cause IPD are represented in PCV-7
  • Recommended since August, 2000
  • 2,4 and 6 months with booster at 12-15 mo

12
Vaccine Efficacy
  • PCV-7 tested in a large NC Kaiser-based
    randomized controlled trial of 37,868 children
  • Efficacy against IPD from vaccine serotypes
  • Fully vaccinated children (4 doses) 97.4
  • Those receiving one or more dose of vaccine 94.
  • Efficacy against IPD from any pneumococcal
    serotype,
  • Those receiving one or more doses 89.1

13
Vaccine Efficacy Post-licensure
  • Multiple post-licensure studies have supported
    the expected reduction in invasive pneumococcal
    disease (IPD)
  • 78-85 drop in rates of IPD in children lt2 years
    of age.
  • Rates of disease from non-vaccine serotypes have
    not increased
  • However, IPD and SBI are still possible, even in
    vaccinated children.

14
How should vaccine change our management?
  • Since IPD is responsible for the majority of SBI
    in infants gt3 months of age
  • And the vaccine is at least 90 effective against
    IPD
  • The risk of SBI in vaccinated children is lt1,
    regardless of WBC count.
  • Therefore, a CBC is unlikely to significantly
    impact the assessment or management of vaccinated
    children.

15
Is this change in management cost-effective?
  • Lee et al (2001) conducted a cost-effectiveness
    analysis of various management strategies for
    infants with FWS
  • Conclusion empiric CBC/blood cx NOT cost
    effective if rates of SBI lt0.5
  • Costs gt300,000 per life saved
  • Rates of SBI lt0.5 in vaccinated infants, based
    on current data

16
Recommendations for vaccinated children 3-36 mo
of age
  • Is the child effectively immunized?
  • At least two doses (3 is better!)
  • 2 weeks from 2nd dose
  • Screen for UTI as for the unvaccinated child
  • Well-appearing, vaccinated children are low risk,
    so blood tests not likely to change management!

17
Case 1
  • Rutabaga is a 9 week old male infant with fever
    at home to 103, parents gave Tylenol.
  • In clinic, T is 37.6, vitals otherwise normal for
    age, baby is well-appearing
  • Exam/hx hint of a cough, mild papular rash
    onchest, feeding well, older sibs with colds
  • Received 1st dose of Prevnar 3 weeks ago
  • Uncircumcised

18
What are the key parts of Rutabagas Hx/PE in
estimating his risk of SBI/UTI?
  • Age 1-3 mo
  • Appearance Non-toxic
  • Fever source
  • Possible viral source? Sick contacts?
  • Uncircumcised
  • Immunization status
  • One dose of PCV-7 is he protected?

19
Partial Vaccination Evidence
  • Efficacy of the vaccine after lt 3 doses is
    unclear at the moment due to lack of sufficient
    data.
  • Kaiser study results suggest that immunity
    against invasive disease is good in partially
    immunized infants
  • Herd immunity protective
  • Two recent studies have demonstrated good
    serotype-specific antibody responses after 2
    doses of the vaccine (Goldblatt, 2006 Huebner
    2002)
  • Vaccination against pneumococcus DOES NOT protect
    against UTI, primarily caused by E. Coli

20
Whats your plan?
  • Cath U/A
  • Negative for LE, nitrites, small blood
  • CBC
  • WBC 18.7, 75 lymphs
  • Blood culture
  • Cant obtain blood culture after multiple sticks
  • What are your options?
  • Try again for blood cultures
  • Treat without cx commit to full course of
    antibiotics
  • No antibiotics, admit for obs
  • No antibiotics, home for obs

21
Another version
  • In a similar case, you obtain blood cultures, but
    are unable to obtain spinal fluid after 3 tries
  • What are your options?
  • Treat without tap
  • Commit to full course for presumed meningitis
  • Try again tomorrow for cell count
  • Dont treat
  • Admit for obs without tap (plan to tap and treat
    if ill-appearing)

22
Case 2
  • Cheyote is 6 month old girl who just received 3rd
    dose of PCV-7 2 days ago
  • She has had a fever for 3 days, has a temp of
    39.8 in clinic, no source for fever on exam or
    history, and is well-appearing
  • What studies, if any, would you do on this
    infant?
  • How do you obtain urine?

23
Bag vs Cath
  • Catheter specimens
  • Current gold standard
  • For culture Sens 95, spec 99
  • Bag
  • Less invasive (?)
  • BUT results difficult to interpret
  • Culture Sens/spec 85

24
Can a bag specimen be used for UA?
  • Bottom line No published data compares
    sensitivity and specificity of UA on bag
    specimens to other types of specimens!
  • UA from bag may have slightly decreased
    specificity compared to cath specimen
  • False positives may result from contamination
    from distal urethra, diaper
  • Avoid in patients in whom false positives are
    unacceptable

25
Predictive value of UA
  • Predictive value refers to the posterior
    probability of disease, given a positive or
    negative test
  • Depends on sensitivity, specificity, and prior
    probability
  • Example For a UA positive for LE only
  • Prior prob PPV NPV
  • 5 20 lt1
  • 10 33 1
  • 20 53 3
  • Which patient is most likely to be impacted?

26
Predictive value of UA
  • Predictive value refers to the posterior
    probability of disease, given a positive or
    negative test
  • Depends on sensitivity, specificity, and prior
    probability
  • Example For a UA positive for LE only
  • Prior prob PPV NPV
  • 5 20 lt1
  • 10 33 1
  • 20 53 3
  • Which patient is most likely to be impacted?

27
Predictive Value The Bottom Line
  • PPV is maximized when PP is high
  • NPV is maximized when PP is low
  • Best use of UA for
  • Low prior prob patient Rule OUT UTI
  • High prior prob patient start empiric treatment

28
Can a bag specimen be sent for culture?
  • False positives are the major concern
  • Contamination rate depends on the population,
    technique, and positive threshold
  • Very low in circ boys
  • As high as 20 in other populations
  • However, false negatives also occur, depending on
    the threshold chosen for positive test
  • For gt100,000 org, sens and spec 85

29
Predictive value of bag culture
  • NPV of bag cx best in low prior prob patient, PPV
    best in high prior prob pt
  • Example
  • Prior prob PPV NPV
  • 5 23 1
  • 10 40 2
  • 20 60 4
  • The only clinically meaningful use of the bag
    culture is to rule OUT UTI in the low prior
    probability patient

30
Predictive value of bag culture
  • NPV of bag cx best in low prior prob patient, PPV
    best in high prior prob pt
  • Example
  • Prior prob PPV NPV
  • 5 23 1
  • 10 40 2
  • 20 60 4
  • The only clinically meaningful use of the bag
    culture is to rule OUT UTI in the low prior
    probability patient

31
Summary Bag specimen
  • Characteristics of UA from bag specimen make it
    most useful to rule out UTI in low probability
    patients
  • Can also be used to start treatment in high risk
    patient
  • Bag culture
  • False positive/negative results are a significant
    risk
  • Neg results helpful in low-prob patients
  • Must weigh the implications of false pos/false
    neg for the patient, against the discomfort of a
    cath

32
Recommendations Collection of Urine Specimen
  • High risk infants, or a child who looks sick
    enough to require IV antibiotics/admission
  • Obtain a catheter specimen for UA and culture
  • Positive UA empiric treatment, confirm with
    culture
  • Lower risk patients
  • If desired, collect bag specimen for screening
    UA
  • Negative UA UTI is unlikely
  • Positive UA consider empiric treatment, but
    confirm with a culture
  • If you send the bag for culture consider the
    clinical implications before you send the test!

33
Case Three
  • Daikon is a 6 week old boy, temp of 101 at home,
    38.7 in clinic
  • Its winter, influenza and RSV are rampant
  • He is well-appearing, without any URI symptoms on
    exam or history, mom says she has had the flu
    and is wondering if he might have the same thing
  • No immunizations yet

34
Key Question
  • Would viral testing change your management?

35
Viral Testing - Evidence
  • The advent of rapid viral testing has added a new
    option for identifying infants at low risk for
    SBI
  • Rapid tests exist for RSV, adeno, paraflu,
    influenza, entero and rotaviruses
  • In general, these tests are more specific than
    they are sensitive, which makes false positives
    extremely rare

36
Viral Testing - Evidence
  • A number of recent studies, mostly retrospective,
    have evaluated the risk of SBI in infants found
    to have a positive viral test
  • Example recent prospective trial (Byington, et
    al 2004) of 1385 febrile infants lt90 days, tested
    for multiple viruses
  • Stratified infants into HR/LR by Rochester
    criteria
  • Among LR infants, risk of SBI low (1-3)
    regardless of viral test
  • Among HR infants, those with viral tests had a
    significantly reduced chance of SBI (16.7 -gt
    5.5)
  • Risk of UTI still clinically significant in HR
    infants (4), while bacteremia occurred in lt1,
    and none had meningitis

37
Recommendations
  • Bottom LineThe negative predictive value of a
    rapid viral test is best in low probability
    patients!
  • Therefore, viral testing is most likely to change
    management in those infants with a low-mod prior
    probability of SBI
  • In very young infants or those at high risk, an
    appreciable risk of UTI remains
  • Consider testing for UTI in infants at high risk
    of UTI, regardless of viral diagnosis

38
Case 3 - Continued
  • You decide to get a CBC and blood culture, a cath
    UA and a rapid viral test for RSV and influenza
  • Results
  • WBC 18, with 67 lymphs
  • Rapid viral test positive for influenza
  • Cath U/A negative
  • What do you want to do?
  • Treat with antibiotics? Admit? Tap?

39
Summary of Recommendations
  • 5 questions to ask about child with FWS
  • 1. Is this child toxic?
  • 2. Is there a source for the fever?
  • 3. Has this child been vaccinated against
    pneumococcus?
  • 4. If its a boy, is he circumcised?
  • 5. Will this child come back if he/she gets
    sick?

40
My Silly Mnemonic
  • If the babys smiling at me
  • And has had Prevnar X 3
  • Skip the CBC
  • But dont forget to collect the pee!
Write a Comment
User Comments (0)
About PowerShow.com